Articles, Behavioral/Cognitive
Arginine Methyltransferase 1 in the Nucleus Accumbens Regulates Behavioral Effects of Cocaine
Yan Li (李燕), Ruiming Zhu (朱睿明), Wenjing Wang (汪文静), Dengqi Fu (付登琦), Jing Hou (侯静), Sen Ji (纪森), Bo Chen (陈波), Zhengtao Hu (扈正桃), Xue Shao (邵雪), Xuri Yu (余旭日), Qian Zhao (赵倩), Baolai Zhang (张宝来), Changman Du (杜长蔓), Qian Bu (卜迁), Chunyan Hu (胡春燕), Yun Tang (唐芸), Lei Zhong (钟磊), Shengyong Yang (杨胜勇), Yinglan Zhao (赵瀛兰) and Xiaobo Cen (岑小波)
Journal of Neuroscience 16 September 2015, 35 (37) 12890-12902; https://doi.org/10.1523/JNEUROSCI.0246-15.2015
Yan Li (李燕)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Ruiming Zhu (朱睿明)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Wenjing Wang (汪文静)
2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, People's Republic of China
Dengqi Fu (付登琦)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Jing Hou (侯静)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Sen Ji (纪森)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Bo Chen (陈波)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Zhengtao Hu (扈正桃)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Xue Shao (邵雪)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Xuri Yu (余旭日)
2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, People's Republic of China
Qian Zhao (赵倩)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Baolai Zhang (张宝来)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Changman Du (杜长蔓)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Qian Bu (卜迁)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Chunyan Hu (胡春燕)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and
Yun Tang (唐芸)
2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, People's Republic of China
Lei Zhong (钟磊)
2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, People's Republic of China
Shengyong Yang (杨胜勇)
2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, People's Republic of China
Yinglan Zhao (赵瀛兰)
2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, People's Republic of China
Xiaobo Cen (岑小波)
1National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China, and

Published eLetters
Guidelines
As a forum for professional feedback, submissions of letters are open to all. You do not need to be a subscriber. To avoid redundancy, we urge you to read other people's letters before submitting your own. Name, current appointment, place of work, and email address are required to send a letter, and will be published with your review. We also require that you declare any competing financial interests. Unprofessional submissions will not be considered or responded to.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Neuroscience
Vol. 35, Issue 37
16 Sep 2015
Arginine Methyltransferase 1 in the Nucleus Accumbens Regulates Behavioral Effects of Cocaine
Yan Li (李燕), Ruiming Zhu (朱睿明), Wenjing Wang (汪文静), Dengqi Fu (付登琦), Jing Hou (侯静), Sen Ji (纪森), Bo Chen (陈波), Zhengtao Hu (扈正桃), Xue Shao (邵雪), Xuri Yu (余旭日), Qian Zhao (赵倩), Baolai Zhang (张宝来), Changman Du (杜长蔓), Qian Bu (卜迁), Chunyan Hu (胡春燕), Yun Tang (唐芸), Lei Zhong (钟磊), Shengyong Yang (杨胜勇), Yinglan Zhao (赵瀛兰), Xiaobo Cen (岑小波)
Journal of Neuroscience 16 September 2015, 35 (37) 12890-12902; DOI: 10.1523/JNEUROSCI.0246-15.2015
Arginine Methyltransferase 1 in the Nucleus Accumbens Regulates Behavioral Effects of Cocaine
Yan Li (李燕), Ruiming Zhu (朱睿明), Wenjing Wang (汪文静), Dengqi Fu (付登琦), Jing Hou (侯静), Sen Ji (纪森), Bo Chen (陈波), Zhengtao Hu (扈正桃), Xue Shao (邵雪), Xuri Yu (余旭日), Qian Zhao (赵倩), Baolai Zhang (张宝来), Changman Du (杜长蔓), Qian Bu (卜迁), Chunyan Hu (胡春燕), Yun Tang (唐芸), Lei Zhong (钟磊), Shengyong Yang (杨胜勇), Yinglan Zhao (赵瀛兰), Xiaobo Cen (岑小波)
Journal of Neuroscience 16 September 2015, 35 (37) 12890-12902; DOI: 10.1523/JNEUROSCI.0246-15.2015
Jump to section
Keywords
Responses to this article
Jump to comment:
No eLetters have been published for this article.